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2944Objective: Open arch interventions after previous cardiac surgery are considered high risk. We reviewed our
outcomes in patients requiring aortic arch reconstruction after previous cardiovascular surgery.
Methods: From March 2000 to March 2014, the data from 168 patients with previous sternotomy requiring
aortic arch replacement were reviewed. The indications for surgery, perioperative data, and outcomes of
reoperation were analyzed.
Results: The mean age was 61  14 years, and 119 were men (70%). The indications for reoperation were
aneurysm (57%), valvular disease (13%), impending rupture (12%), aortic dissection (9.0%), and endocarditis
(7.7%). The median time from the previous operation to reoperation was 7 years. The mean aortic diameter
was 55 mm. Total or partial arch replacement was performed in 38% and 62% of patients, respectively. Fifty-
five patients (32.7%) had undergone previous ascending dissection repair and 45 (26.8%) had previous coronary
bypass surgery. Deep hypothermic circulatory arrest was used in all. Selective cerebral perfusion was used in 39%
and retrograde cerebral perfusion in 14%. The incidence of permanent stroke was 5.4%. Operative mortality (30-
day) was 8.3%. Older age (odds ratio, 1.05; 95% confidence interval, 1.00-1.10; P ¼ .04), New York Heart As-
sociation class III/IV (odds ratio, 3.15; 95% confidence interval, 1.01-9.86; P ¼ .04), and extracorporeal circula-
tion time (odds ratio, 1.01; 95% confidence interval, 1.00-1.02; P¼ .001) were predictors of perioperative death.
The median follow-up was 3.0 years. Survival was 85%, 78%, and 68% at 1, 3, and 5 years, respectively.
Conclusions: Reoperations to address the aortic arch have acceptable mortality and morbidity. Open repair
under circulatory arrest is the benchmark to which endovascular therapies should be compared. (J Thorac
Cardiovasc Surg 2014;148:2944-50)Open aortic arch replacement in patients who have under-
gone previous cardiovascular surgery can be technically
challenging. Despite assertions that emerging endovascular
technology carries a lower risk in the treatment of aortic arch
pathology comparedwith open approaches, scant reports are
available to delineate the contemporary risks of these com-
plex open arch operations. The overall operative mortality
and incidence of stroke in patients undergoing distal
ascending aortic or proximal arch surgery in North America
have been reported at 11.6% and 11%, respectively.1 Up to
5% of patients after ascending aortic surgery will require
reoperation involving the aortic arch.2 The reoperations
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Such patients in need of re-do sternotomy and arch replace-
ment have typically been either denied surgery or referred to
high-volume aortic centers. Because the risks of reoperation
are perceived to be greater than those for primary aortic arch
repair,1 often without concrete data, many of these patients
have been channeled toward hybrid reconstructions or
denied repair, even at the referred high-volume centers.
The aim of the present study was to establish contemporary
data for assessing the risk profile in patients who require
re-do sternotomy to repair or re-repair the aortic arch.METHODS
From March 2000 to March 2014, 650 patients underwent aortic arch
surgery with hypothermic circulatory arrest at the Mayo Clinic (Rochester,
Minn). Of these patients, we identified 172 (26%) who had undergone
aortic arch surgery after previous cardiac or aortic surgery. We included
patients who had undergone 1 or multiple previous operations through a
median sternotomy. The Mayo Clinic College of Medicine institutional
review board reviewed and approved the present clinical study, and all
but 4 patients authorized the use of their clinical data for clinical research.
Those 4 patients were excluded from additional analysis, and 168 patients
constituted the focus of our study. Our cardiovascular database and the
hospital electronic medical records were used to obtain the data for the
present study. The patient characteristics, operative interventions, and
morbidity and mortality data were collected, keeping with the standard
definitions set forth by the Society of Thoracic Surgeons as a part of the Na-
tional Adult Cardiac Surgery Database. Operative mortality was defined asgery c December 2014
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
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hospitalization. Surgery was considered emergency when the patients were
transferred immediately to the operating room once the diagnosis had been
made. Surgery was defined as urgent when performed on the day of
diagnosis. Follow-up data were obtained from all repeat visits and from
health assessment questionnaires sent to the patients and families at 1, 3,
5, and 10 years postoperatively. These data were supplemented by written
correspondence from the referral physicians or patients and by checking
the vital status from the Social Security Death Index.
Perioperative Management
All patients had undergone preoperative echocardiographic evaluation
and computed tomography to define the relations of the intrathoracic struc-
tures. The specific aortic information evaluated in all patients included the
diameter, wall integrity, atherosclerotic disease, and branch perfusion in the
dissections. If feasible, coronary angiography was obtained for patients
>40 years old and for younger patients if coronary intervention had been
performed at the first operation. The patients were monitored by arterial
lines placed in 1 of the upper extremities (often both radials), with 1
femoral line added in most patients. The goal was to monitor the regional
perfusion pressures during arch reconstruction. Central venous access,
large bore peripheral vein access, and a pulmonary artery catheter were
used routinely. The core (bladder) and nasopharyngeal temperatures
were monitored in all patients. Standardmethods for repeat median sternot-
omy or bilateral thoracosternotomy for single-stage extensive aortic repair
were used. Cardiopulmonary bypass (CPB) was initiated at an indexed flow
of 2.4 L/min/m2, and the desired level of hypothermia was achieved by
actively cooling the patient with a heat exchanger connected to the oxygen-
ator, keeping a gradient of no more than 10C. Cannulation strategies were
customized to the patient’s anatomy as feasible, and safe central cannula-
tion was preferred.3,4 Central cannulation was instituted with conventional
arterial cannulas in the nondissected aorta. If the aorta was dissected,
peripheral cannulation was commonly used, with direct cannulation over
a wire using echocardiographic control to guide the tip of the cannula
into the true lumen. Peripheral arterial cannulation was achieved through
axillary or femoral artery cannulation through an 8- to 10-mmDacron graft
or by direct arterial femoral cannulation using the Seldinger technique.5 If
treacherous anatomy or computed tomographic evidence of rupture was
demonstrated, establishment of peripheral cannulation was selected as
the first operative step.When the proximity of the cardiovascular structures
precluded safe reentry, full CPBwithout cooling was used to decompressed
the circulation before sternal sawing was performed. In cases in which
contained vascular rupture was present, deep hypothermic CPB was estab-
lished before redo sternotomy. Neurologic monitoring was accomplished
using the bispectral index and/or continuous electroencephalography. All
patients were cooled to a target temperature and/or electroencephalo-
graphic silence. The patient was then placed in the Trendelenburg position,
and circulation to the body was interrupted. For extensive arch repairs,
selective antegrade cerebral perfusion (ACP) was performed either using
the axillary cannula or by individually cannulating the arch vessels at flows
of 10 to 15 mL/kg/min, with a perfusion pressure of 50 to 60 mm Hg.6
When simple arch reconstruction could be accomplished quickly
(<30 minutes), isolated circulatory arrest or retrograde cerebral perfusion
was used in most cases.7 The techniques of arch reconstruction ranged
from hemiarch repair to complete intrathoracic aorta replacement through
a bilateral thoracosternotomy. In cases of total arch replacement, the archThe Journal of Thoracic and Carvessels were connected to the Dacron arch graft using either a Carrel patch
or by individual branch reimplantation. Cold blood cardioplegia in a 4:1
blood to crystalloid solution at 4C was used for myocardial protection
in all patients. An antegrade induction dose of 800 to 1000 mL was
administered in the aortic root or coronary ostia. This was supplemented
with repeated doses of antegrade and/or retrograde cardioplegia according
to the clinical details and surgeon preference. Concomitant cardiac
procedures were performed during cooling and rewarming.
Statistical Analysis
Statistical analyses were performed using SAS software, version 9.1
(SAS Institute, Inc, Cary, NC). Descriptive statistics for categorical
variables are reported as frequencies and percentages and continuous
variables as the mean  standard deviation. Potential risk factors for early
mortality were assessed using logistic regression models.
The Kaplan-Meier method was used to estimate late survival, with
the estimates extending to 5 years. Observed mortality was compared
using a 1-sample log-rank test to the expected survival of an age- and
sex-matched Minnesota population for the entire follow-up period.RESULTS
The mean age at the time of re-do sternotomy/thoracoster-
notomy arch surgery was 61  14 years, and 119 patients
were men (70.8%). The median time from the previous
cardiovascular surgery to reoperation was 7 years (range,
15 days to 48 years). One hundred seventeen patients
(69.6%) had undergone their previous operation at a different
institution and the remaining patients had their previous oper-
ation at Mayo Clinic Rochester. The patient characteristics
and details of the previous cardiac operations are listed in
Table 1. Forty-seven patients (27.9%) had a bicuspid aortic
valve, 16 (9.5%) had Marfan disease, and 2 (1.2%) had
Loeys-Dietz syndrome. Giant cell arteritis was documented
from the surgical specimens of 10 patients (5.9%). The over-
all median aortic diameter was 55 mm (range, 29-88 mm).
Heart failure was documented in 104 patients (61.9%),
with evidence of New York Heart Association class III or
IV in 65 (38.7%). Twenty-two patients (14.4%) had
undergone 2 previous sternotomies and 6 (3.6%) had
undergone3previous sternotomies. Surgerywas performed
urgently in 24 patients (14.3%). Two patients had a stent
graft in the aortic arch at the time of reoperation. One patient
underwent total arch repair with a hybrid procedure.Indications for Surgery and Repair Type
The primary indication for reoperation was aneurysmal
disease in 96 patients (57%). Severe valvular disease
(primarily aortic valve) was the leading indication in 23
patients (13%). Aortic pseudoaneurysm or contained
rupture was the third most common indication, present in
21 patients (12%). The other indications for surgery were
acute aortic dissection in 15 patients (9%) and infective
endocarditis in 13 (7.7%). Aneurysmal expansion of a
chronic aortic dissection was present in 14 patients in the
aneurysmal group (8.3% of the total).diovascular Surgery c Volume 148, Number 6 2945
TABLE 1. Patient characteristics and details of previous cardiac
operations
Variable Value
Patient data
Age (y) 61  14
Male sex 119 (70.8)
COPD 7 (4.7)
Hypertension 88 (52.4)
Chronic renal failure (creatinine>1.4 mg/dL) 36 (21.4)
Dialysis 3 (1.8)
Diabetes mellitus 19 (11.3)
NYHA class III-IV 65 (38.7)
Cerebrovascular disease 46 (27.4)
Previous CVA 31 (18.5)
Peripheral vascular disease 21 (12.5)
Coronary artery disease 75 (44.6)
Previous AMI 19 (11.3)
Marfan syndrome 16 (9.5)
LVEF (%) 58  10
Aortic diameter (mm) 55  12
Aortic valve regurgitation (grade III-IV) 53 (31.5)
Aortic valve stenosis (grade III-IV) 17 (10)
Previous cardiac interventions
Arch replacement 39 (23.2)
Hemiarch 34 (20.2)
Total arch* 5 (3)
Ascending aorta replacement 93 (55.4)
Type A aortic dissection repair 55 (32.7)
CABG 45 (26.8)
Aortic valve replacement 52 (31)
Aortic root surgery 56 (33)
Bentall 26 (15.5)
Root repair 17 (10)
Homograft 10 (6)
Ross 3 (1.8)
Data presented as mean  standard deviation or n (%). COPD, Chronic obstructive
pulmonary disease; NYHA, New York Heart Association; CVA, cerebrovascular
accident; AMI, acute myocardial infarction; LVEF, left ventricular ejection fraction;
CABG, coronary artery bypass grafting. *One patient had undergone a previous
hybrid total arch procedure.
TABLE 2. Surgical indications and operative data
Variable Value
Indications for surgery
Aneurysm 96 (57)
Valvular 23 (13.7)
Pseudoaneurysm 21 (12.5)
Acute type A dissection 15 (8.9)
Endocarditis 13 (7.7)
Aortic arch reconstruction type
Ascending plus hemiarch 104 (61.9)
Ascending plus total arch 25 (14.9)
Total arch 28 (16.7)
Single-stage total thoracic aortic repair (clamshell) 11 (6.5)
Emergency 14 (8.3)
Urgent 10 (6)
Perfusion data
Cardiopulmonary bypass (min) 211  75
Cardiac ischemia (min) 119  66
Circulatory arrest body (min) 37  26
Circulatory arrest brain (min) 16  14
Lower temperature (core) achieved (C) 18  6
Arterial cannulation
Aorta 69 (41)
Axillary 74 (44)
Femoral 24 (14)
Innominate artery 1 (0.6)
Venous return
Central 135 (80.4)
Femoral vein 33 (19.6)
Concomitant cardiac procedures
Aortic root replacement 34 (20.2)
CABG 30 (17.9)
Redo root replacement 23 (13.7)
Redo aortic valve replacement 20 (11.9)
Aortic valve replacement 18 (10.7)
Mitral valve surgery 7 (4.2)
Tricuspid valve surgery 5 (3)
Valve-sparing root replacement 4 (2.4)
Data presented as n (%) or mean  standard deviation. CABG, Coronary artery
bypass grafting.
Acquired Cardiovascular Disease Quintana et al
A
C
DThe details of the indications, type of aortic repair, and
concomitant cardiac procedures are listed in Table 2. One
hundred nine patients (65%) underwent partial arch
replacement and 59 (35%) underwent total arch replace-
ment. Island-type reimplantation of the arch vessels was
performed in 12 patients undergoing total arch replace-
ment (19.7%), with individual branch reimplantation
performed in 49 (80.3%). Twelve patients (7.1%) underwent
total arch replacement and additional partial or total
descending thoracic aorta replacement by way of a bilateral
thoracosternotomy. Twenty-one patients (12.5%) underwent
a classic elephant trunk procedure at total arch replacement in
preparation for future descending thoracic aortic replace-
ment, either open or endovascular. None of the patients
in the present series underwent a frozen elephant trunk
procedure. A cryopreserved human homograft was used in2946 The Journal of Thoracic and Cardiovascular Sur14 patients (8.3%), with all remaining patients undergoing
aortic replacement with a Dacron graft.
Reentry and Perfusion Strategy
Individualized strategies to achieve safe thoracic reentry
and the specific organ protection techniques used in the
present series are listed in Table 2. Unexpected aortic injury
at reentry that required emergency institution of CPB
occurred in 2.4% of the reentries (4 cases) in our series.
A retrospective review of the preoperative computed tomo-
graphic angiograms revealed flattening of the ascending
aorta in contact with the posterior wall of the sternum in 2
patients. Seventy-four individuals (44%) underwent
peripheral cannulation by way of the axillary artery
before repeat sternotomy. In 10 patients (6%), CPB was
established before re-do sternotomy, with 14 patientsgery c December 2014
TABLE 3. Postoperative outcomes and complications
Outcome Value
Operative mortality 14 (8.3)
ICU length of stay (d) 3.3  5.4
Hospital length of stay (d) 10.1  7.5
Complications
Stroke (permanent) 9 (5.4)
Spinal cord deficit 1 (0.6)
Reoperation for bleeding 16 (9.6)
Tamponade 4 (2.4)
Low cardiac output syndrome 14 (8.5)
Myocardial infarction 6 (3.6)
ECMO 3 (1.8)
IABP 7 (4.2)
Renal failure dialysis 7 (4.2)
Respiratory (pneumonia/atelectasis/pleural effusion) 20 (12.2)
Mesenteric (ischemia/hemorrhage) 4 (2.4)
Sepsis 8 (4.9)
Wound complication (infection/dehiscence) 7 (4.2)
Laryngeal nerve injury 11 (6.7)
Data presented as n (%) or mean  standard deviation. ICU, Intensive care unit;
ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump.
TABLE 4. Predictors of perioperative mortality
Variable OR (95% CI) P value
Age (y) 1.05 (1.00-1.10) .04*
Female sex 0.64 (0.17-2.40) .5
NYHA class III-IV 3.15 (1.01-9.86) .04*
Coronary artery disease 0.57 (0.19-1.74) .3
Peripheral vascular disease 0.48 (0.12-1.91) .3
LVEF 1.00 (0.94-1.05) .9
CVA 0.81 (0.21-3.11) .8
Creatinine 1.39 (0.76-2.55) .3
Marfan syndrome 1.72 (0.21-13.95) .6
Redo arch 0.51 (0.16-1.62) .3
Type of arch surgery 1.42 (0.47-4.33) .5
Circulatory arrest time (brain) 1.01 (0.97-1.05) .5
Circulatory arrest time (body) 1.01 (0.99-1.03) .07
Cannulation site 1.26 (0.60-2.65) .5
Extracorporeal circulation time 1.01 (1.00-1.02) .001*
Cardiac ischemic time 1.00 (1.00-1.01) .06
Previous CABG 0.45 (0.14-1.38) .2
Previous type A repair 1.86 (0.50-6.99) .4
CABG 0.77 (0.20-2.98) .7
Redo aortic root 2.16 (0.27-17.40) .5
OR, Odds ratio; CI, confidence interval; NYHA, New York Heart Association; LVEF,
left ventricular ejection fraction; CVA, cerebrovascular accident; CABG, coronary
artery bypass grafting. *Statistically significant.
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perfusion or with hypothermic circulatory arrest. Eight
patients (4.8%) required a change in the overall planned
perfusion strategy during the operation because of either
inadequate flow or malperfusion.
For all arch replacements, after deep hypothermia was
achieved, ACP was used in 66 patients (39.3%) and retro-
grade cerebral perfusion in 23 (13.7%), with 79 patients
(47%) not receiving adjunct cerebral perfusion during the
circulatory arrest period. For patients with extensive aortic
arch reconstruction, ACP was delivered unilaterally in 20
patients (30.3%) and bilaterally in 46 (69.7%). The routes
of ACP administration in this population were direct cannu-
lation of the arch vessels with individual cannulas in 16
(24.2%) and different configurations involving perfusion
by way of the right axillary artery with or without individual
cannulas to the left carotid and left subclavian artery in 60.
Early Mortality and Complications
There were 14 operative deaths (8.3%). Three patients
could not be weaned successfully off CPB and died in the
operating room, because they were not candidates for
mechanical support. Five patients died in the intensive care
unit of complications related to low cardiac output. Two
patients died of aortic rupture, 1 in the hospital after repair
of a mycotic pseudoaneurysm and 1 at home while waiting
for completion of a staged aortic reconstruction. An addi-
tional 2 patients died of perioperative stroke (cerebrovascular
accident). An 83-year-old patient developed acute renal
failure requiring dialysis. In accordance with his living will,
dialysis was not performed, and he was allowed to die. One
patient died of unknown reasons at homewithin 30 days after
surgery, and an autopsy was not performed.The Journal of Thoracic and CarA prolonged hospital stay (defined as>14 days) was
required for 31 patients (18.4%) and a prolonged intensive
care unit stay (>10 days) for 10 patients (5.9%). The
perioperative outcomes are detailed in Table 3. The results
of univariate logistic regression of variables predictive of
operative mortality are listed in Table 4.Long-Term Results and Reoperations
Follow-up information after surgery was available for the
entire study population (100%), and the mean follow-up
time was 3 years. The median survival for the entire
population, including operative mortality, was 7.6 years.
After the perioperative period, the causes of death were
aortic disease-related complications in 2 patients (5.2%),
heart failure in 9 (23.7%), cerebrovascular accident in 3
(7.9%), infections in 3 (7.9%), trauma or unrelated medical
conditions in 3 (7.9%), and unknown reasons in 18
(47.4%).
The conditioned overall survival (excluding perioperative
mortality) for this population was 93% (95% confidence
interval [CI], 88%-98%), 86% (95% CI, 79%-93%),
and 77% (95% CI, 69%-87%), at 1, 3, and 5 years,
respectively. Compared with an age- and sex-matched
population for whom the expected survival was 88% at
5 years, the difference was significant (P<.001; Figure 1).
Patients with previous coronary artery bypass grafting
had worse long-term outcomes than the remaining patients,
with a 5-year survival of 52% versus 76% (P ¼ .003;
Figure 2). The presence of a previous type A dissectiondiovascular Surgery c Volume 148, Number 6 2947
FIGURE 1. Compared with an age- and sex-matched population, patients
undergoing redo sternotomy arch replacement had lower survival at 5 years
(P<.001).
FIGURE 2. Overall mortality during follow-up stratified by whether the
previous operation included coronary artery bypass grafting (CABG).
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long-term survival (P ¼ .21 and P ¼ .44, respectively).
The survival of patients operated on for endocarditis was
36% at 5 years.
Seventeen patients required late aortic reoperation. The
reoperation rate at 5 years was 17% (95% CI, 8%-26%).
Re-do aortic valve replacement was performed in 4 patients
(2 for endocarditis), open thoracoabdominal repair in 6, de-
scending thoracic replacement in 4, and endovascular aortic
repairs in 3.
DISCUSSION
Aortic arch surgery has seen significant improvement in
outcomes during the past decade. Also, endovascular treat-
ment of all aortic pathologic findings has progressed to the
point that it is now starting to be used to treat aneurysms
involving the aortic arch. Endovascular techniques to treat
the aortic arch are still in their infancy and continue to carry
a high risk of neurologic injury. Although the appropriate
role of endovascular arch repair will eventually be defined,
in this early stage of development, its application has often
been justified by the perceived prohibitive risk of open
aortic arch surgery. The data supporting the perceived
high risk of open aortic arch intervention has been highly
variable, with stroke rates ranging from 2% to 17%, the
lowest rate for hemiarch replacements and the highest for
the more complex repairs. The reported mortality for
open arch repairs in published studies has ranged from
5.2% to 26%.1,6,8-11 Furthermore, even more limited data
are available for the surgical results of arch surgery in the
reoperative cardiac scenario.2 In isolated reports,12 mortal-
ity was not increased in transverse arch reoperations
compared with primary arch surgery.
In the present study, we sought to better define the
outcomes of higher risk patients undergoing aortic arch sur-
gery: those requiring redo sternotomy. The results achieved
showed acceptable mortality of 8.3% despite the many2948 The Journal of Thoracic and Cardiovascular Surchallenging clinical scenarios encountered. Even with a
preoperative stroke incidence of 18.5%, the postoperative
stroke rate was only 5.4%. Furthermore, this population
included patients with very complex problems such as acute
aortic dissection, endocarditis, and many pseudoaneurysms
(mostly infectious in etiology), in addition to the prevalence
of New York Heart Association class III and IV heart
failure.
A detailed evaluation of the individual anatomic risk
factors extracted from the imaging studies and previous
operative reports helped define the best strategy to
achieve safe thoracic reentry. Establishment of CPB
before sternotomy in 14.3% of patients might have
contributed to the low incidence of unexpected injury
at redo sternotomy (2.4%). Universal use of hypother-
mia, with increasing use of selective ACP during the
study period, kept the rate of neurologic injury to a min-
imum. Most of the early deaths were secondary to low
cardiac output syndromes in patients with established se-
vere heart failure preoperatively.
Although most of the patients evaluated had undergone
hemiarch replacement, the extent of arch reconstruction
did not affect the overall outcome.
Our clinical experience, especially during the past 5
years, has shown that many of the patients presenting
with arch aneurysms after previous cardiovascular interven-
tions are referred late, often after other hybrid approaches
have failed. It is our sense that a general reluctance exists
on the part of the cardiac surgical community to treat
such patients, who are then offered alternate treatment by
‘‘endovascular specialists.’’
Hybrid aortic repairs involving a variety of configura-
tions in arch branch rerouting and different landing zones
carry a pooled risk of mortality exceeding 10% and a peri-
operative stroke rate of 0.8% to 18.8%.13 However, many
of the published series have included hybrid replacement
of less than a total arch (zone 1 and zone 2 coverage), mak-
ing interpretation of the data rather difficult. In a moregery c December 2014
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arch endovascular repair), the best results were in those pa-
tients who had undergone ascending aortic replacement first
to create a proximal landing zone for the endovascular arch
exclusion, often requiring a period of circulatory arrest.14
The findings from that report would suggest that circulatory
arrest is not, itself, a significant risk and that embolic events
from the diseased ascending aorta continue to be the more
vexing problem.
As others have also reported,15 our results have demon-
strated that open reoperations with direct anatomic recon-
struction of the arch conducted in high-volume centers
should be the benchmark by which other approaches are
scrutinized. Using such a benchmark, newer technology
needs to be realistically appraised and compared with
contemporary therapies, at the same time resisting the enor-
mous financial pressure exerted by the medical device
industry.
An additional factor often minimized by catheter-based
practitioners and manufacturers is the need for reinterven-
tion. In our series, the freedom from reoperation at 5 years
was 83%, with all but 2 patients receiving intervention
distal to the aortic arch repair. The only 2 patients requiring
additional arch reoperation had had infectious pseudoaneur-
ysms at their previous intervention. This low reoperation
rate is superior to the high reintervention rates recently re-
ported with endovascular approaches.16,17 With a stable
aorta, this patient group, despite significant cardiovascular
risk factors, fared reasonably well in the long term
compared with an age-matched general population (77%
vs 88% 5-year survival), further demonstrating that open
aortic arch repair is a durable solution to complex aortic
pathology.
The current trends in healthcare management have been
moving toward ultraspecialization, together with the
merging of physicians of differing backgrounds into spe-
cific disease management teams.18,19 Only such teams can
be capable of offering open and endovascular options
with equally outstanding results. It is unfortunate to
occasionally observe that a given patient has been offered
the intervention most comfortable to the surgeon
consulted rather than the best operation available. Only a
high-volume aortic center is likely to have the team
approach required to critically assess all risk factors and
anatomic variables and be able to offer the right operation
to a given patient and, in the process, improve on the pres-
ently accepted aortic surgical outcomes in North America.1
Study Limitations
The present study had the limitations inherent to a single-
center retrospective cohort analysis. Owing to the low num-
ber of events (operative deaths), multivariate analysis to
further define the predictors of perioperative death was
not possible. The present study does not reflect theThe Journal of Thoracic and Caroutcomes of true redo arch procedures but, rather, reopera-
tions involving arch surgery after previous cardiac surgery.
Additionally, our population was a heterogeneous popula-
tion that included ‘‘all comers’’ to arch surgery after a pre-
vious cardiac operation. Thus, different approaches to organ
protection, surgical strategies, and repairs were used. It was
not the aim of the present study to demonstrate that one
approach is best but to acknowledge that in those clinical
scenarios the therapy was customized. Another limitation
of the present study was that the patients underwent
different extensions of arch repair, with more than one
half undergoing aggressive hemiarch repair. Although the
surgical complexity of surgical arch reconstruction depends
on the extension of the arch repair, physiologically, no dif-
ference could be demonstrated when stratified by the type of
arch reconstruction. We sought to establish the outcomes of
this complex clinical scenario. No randomized clinical trials
on this issue comparing the results of open surgery and en-
dovascular interventions have been performed.CONCLUSIONS
Open aortic arch repair after cardiovascular surgery
under circulatory arrest is the benchmark to which endovas-
cular therapies should be compared. This arch repair tech-
nique is durable and provides good midterm results.
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